Search

everythinglearnresearchcommunity

for

Search:↓

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

The treatment is safe and shows promise for metastatic breast cancer.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Imatinib can cause hair loss due to lichen planopilaris.

Certain drugs that block specific enzymes can help treat prostate diseases.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Using special RNA to target a mutant gene fixed hair problems in mice.

Calretinin can help identify certain skin structures and tumors.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.